Apr 22 | Oct 21 | Apr 21 | Oct 20 | Apr 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 578.70M | $ 558.40M | $ 698.10M | $ 737.20M | $ 808.10M |
Total Assets | $ 9.18B | $ 10.35B | $ 10.73B | $ 11.15B | $ 13.22B |
Total Debt | $ 4.25B | $ 4.74B | $ 4.82B | $ 4.89B | $ 5.12B |
Net Debt | $ 3.67B | $ 4.18B | $ 4.12B | $ 4.15B | $ 4.31B |
Total Liabilities | $ 6.53B | $ 7.53B | $ 7.67B | $ 7.93B | $ 8.22B |
Stockholders Equity | $ 2.65B | $ 2.82B | $ 3.06B | $ 3.22B | $ 5.00B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |